Your browser doesn't support javascript.
loading
Bayesian causal network modeling suggests adolescent cannabis use accelerates prefrontal cortical thinning.
Owens, Max M; Albaugh, Matthew D; Allgaier, Nicholas; Yuan, Dekang; Robert, Gabriel; Cupertino, Renata B; Spechler, Philip A; Juliano, Anthony; Hahn, Sage; Banaschewski, Tobias; Bokde, Arun L W; Desrivières, Sylvane; Flor, Herta; Grigis, Antoine; Gowland, Penny; Heinz, Andreas; Brühl, Rüdiger; Martinot, Jean-Luc; Martinot, Marie-Laure Paillère; Artiges, Eric; Nees, Frauke; Orfanos, Dimitri Papadopoulos; Lemaitre, Herve; Paus, Tomás; Poustka, Luise; Millenet, Sabina; Fröhner, Juliane H; Smolka, Michael N; Walter, Henrik; Whelan, Robert; Mackey, Scott; Schumann, Gunter; Garavan, Hugh.
Afiliação
  • Owens MM; Department of Psychiatry, University of Vermont Larner College of Medicine, Burlington, VT, USA. owensmax03@gmail.com.
  • Albaugh MD; Department of Psychiatry, University of Vermont Larner College of Medicine, Burlington, VT, USA.
  • Allgaier N; Department of Psychiatry, University of Vermont Larner College of Medicine, Burlington, VT, USA.
  • Yuan D; Department of Psychiatry, University of Vermont Larner College of Medicine, Burlington, VT, USA.
  • Robert G; Psychiatry Department, University of Rennes 1, Rennes, France.
  • Cupertino RB; Adult University Psychiatry Department, Guillaume Régnier Hospital, Rennes, France.
  • Spechler PA; U1288 Empenn, UMR 6074, IRISA, Rennes, France.
  • Juliano A; Department of Psychiatry, University of Vermont Larner College of Medicine, Burlington, VT, USA.
  • Hahn S; Laureate Institute for Brain Research, Tulsa, OK, USA.
  • Banaschewski T; Department of Psychiatry, University of Vermont Larner College of Medicine, Burlington, VT, USA.
  • Bokde ALW; Department of Psychiatry, University of Vermont Larner College of Medicine, Burlington, VT, USA.
  • Desrivières S; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Flor H; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.
  • Grigis A; Centre for Population Neuroscience and Precision Medicine (PONS), Institute of Psychiatry, Psychology & Neuroscience, SGDP Centre, King's College London, London, UK.
  • Gowland P; Institute of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, Mannheim, Germany.
  • Heinz A; Department of Psychology, School of Social Sciences, University of Mannheim, Mannheim, Germany.
  • Brühl R; NeuroSpin, CEA, Université Paris-Saclay, F-91191, Gif-sur-Yvette, France.
  • Martinot JL; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, UK.
  • Martinot MP; Department of Psychiatry and Psychotherapy Campus Charité Mitte, Charité-Universitätsmedizin, corporate member of Freie Universität Berlin & Humboldt-Universität zu Berlin, Berlin, Germany.
  • Artiges E; Physikalisch-Technische Bundesanstalt (PTB), Braunschweig and Berlin, Braunschweig, Germany.
  • Nees F; Institut National de la Santé et de la Recherche Médicale, INSERM U A10 "Trajectoires développementales en psychiatrie"; Université Paris-Saclay, Ecole Normale supérieure Paris-Saclay, CNRS, Centre Borelli, Gif-sur-Yvette, France.
  • Orfanos DP; Institut National de la Santé et de la Recherce Médicale, INSERM U A10 "Trajectoires développementales & psychiatrie", University Paris-Saclay, Ecole Normale Supérieure Paris-Saclay, CNRS; Centre Borelli, Gif-sur-Yvette, France.
  • Lemaitre H; AP-HP. Sorbonne Université, Department of Child and Adolescent Psychiatry, Pitié-Salpêtrière Hospital, Paris, France.
  • Paus T; Institut National de la Santé et de la Recherche Médicale, INSERM U1299 "Trajectoires développementales en psychiatrie"; Ecole Normale supérieure Paris-Saclay, Université Paris-Saclay, Université de Paris, Centre Borelli; Gif-sur-Yvette, & Department of Psychiatry, EPS Barthélémy Durand, Etampes
  • Poustka L; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Millenet S; Institute of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, Mannheim, Germany.
  • Fröhner JH; Institute of Medical Psychology and Medical Sociology, University Medical Center Schleswig Holstein, Kiel University, Kiel, Germany.
  • Smolka MN; NeuroSpin, CEA, Université Paris-Saclay, F-91191, Gif-sur-Yvette, France.
  • Walter H; NeuroSpin, CEA, Université Paris-Saclay, F-91191, Gif-sur-Yvette, France.
  • Whelan R; Institut des Maladies Neurodégénératives, CNRS UMR 5293, Université de Bordeaux, Centre Broca Nouvelle-Aquitaine, Bordeaux, France.
  • Mackey S; Departments of Psychiatry and Neuroscience, Faculty of Medicine and Centre Hospitalier Universitaire Sainte-Justine, University of Montreal, Montreal, QC, Canada.
  • Schumann G; Departments of Psychology, University of Toronto, Toronto, ON, Canada.
  • Garavan H; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Transl Psychiatry ; 12(1): 188, 2022 05 06.
Article em En | MEDLINE | ID: mdl-35523763
ABSTRACT
While there is substantial evidence that cannabis use is associated with differences in human brain development, most of this evidence is correlational in nature. Bayesian causal network (BCN) modeling attempts to identify probable causal relationships in correlational data using conditional probabilities to estimate directional associations between a set of interrelated variables. In this study, we employed BCN modeling in 637 adolescents from the IMAGEN study who were cannabis naïve at age 14 to provide evidence that the accelerated prefrontal cortical thinning found previously in adolescent cannabis users by Albaugh et al. [1] is a result of cannabis use causally affecting neurodevelopment. BCNs incorporated data on cannabis use, prefrontal cortical thickness, and other factors related to both brain development and cannabis use, including demographics, psychopathology, childhood adversity, and other substance use. All BCN algorithms strongly suggested a directional relationship from adolescent cannabis use to accelerated cortical thinning. While BCN modeling alone does not prove a causal relationship, these results are consistent with a body of animal and human research suggesting that adolescent cannabis use adversely affects brain development.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Problema de saúde: 2_sustancias_psicoativas / 8_cannabis_related_disorders / 8_cocaine_other_stimulant_related_disorders / 8_hallucinogen_related_disorders Assunto principal: Cannabis / Transtornos Relacionados ao Uso de Substâncias / Alucinógenos Tipo de estudo: Prognostic_studies Limite: Adolescent / Humans Idioma: En Revista: Transl Psychiatry Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Problema de saúde: 2_sustancias_psicoativas / 8_cannabis_related_disorders / 8_cocaine_other_stimulant_related_disorders / 8_hallucinogen_related_disorders Assunto principal: Cannabis / Transtornos Relacionados ao Uso de Substâncias / Alucinógenos Tipo de estudo: Prognostic_studies Limite: Adolescent / Humans Idioma: En Revista: Transl Psychiatry Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
...